XML 19 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 40,173,386 $ 37,853,947
Marketable securities 0 15,014,750
Accounts receivable 2,335,911 13,327,364
Unbilled receivable 1,636,539 0
Prepaid and other current assets 3,612,175 2,962,903
Total current assets 47,758,011 69,158,964
Other assets    
Property and equipment, net 70,668 78,107
Right of use assets - operating leases 733,224 999,567
Patents and patent applications, net 10,942 11,628
Other non-current assets 251,599 179,532
Total assets 48,824,444 70,427,798
Current liabilities    
Accounts payable and accrued liabilities 3,101,419 3,369,848
Accrued salaries and wages 1,226,029 201,254
Royalty payable 439,807 2,920,148
Deferred revenue 0 16,618
Operating leases - current 227,413 337,690
Total current liabilities 4,994,668 6,845,558
Long-term liabilities    
Operating leases - long term 523,043 673,347
Convertible debt, net of unamortized discount 13,710,422 16,069,085
Total liabilities 19,228,133 23,587,990
Stockholders' equity    
Common stock; par value $0.001; 200,000,000 shares authorized; 5,122,575 and 4,909,846 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively 5,121 4,910
Additional paid-in capital 115,438,991 108,569,988
Accumulated other comprehensive loss (243,150) (54,815)
Accumulated deficit (85,604,651) (61,680,275)
Total stockholders' equity 29,596,311 46,839,808
Total liabilities and stockholders' equity $ 48,824,444 $ 70,427,798